Clinical Outcomes and Non-Invasive Testing in Metabolic Dysfunction-Associated Steatohepatitis With Cirrhosis: A Systematic Review - PubMed
3 hours ago
- #cirrhosis
- #MASH
- #systematic review
- Systematic review assesses clinical outcomes and non-invasive tests in MASH with cirrhosis.
- Transplant-free survival is lower in patients with compensated cirrhosis and type 2 diabetes.
- Decompensation risk factors include presence of varices and type 2 diabetes.
- Male sex, type 2 diabetes, and high Child-Turcotte-Pugh score are HCC risk factors.
- Limited evidence on prognostic prediction models for liver-related events in MASH cirrhosis.
- Non-invasive tests for predicting outcomes are studied but with varying outcome definitions.